[{"id":"34480011-e1f9-46ba-a75f-ac6c6fd9bd0d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05728541","created_at":"2023-02-15T18:02:59.911Z","updated_at":"2024-07-02T16:35:55.268Z","phase":"Phase 1","brief_title":"Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors","source_id_and_acronym":"NCT05728541","lead_sponsor":"CSPC Ouyi Pharmaceutical Co., Ltd.","biomarkers":" HER-2 • ER","pipe":"","alterations":" ","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SYH2043"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 367","initiation":"Initiation: 03/01/2023","start_date":" 03/01/2023","primary_txt":" Primary completion: 02/01/2026","primary_completion_date":" 02/01/2026","study_txt":" Completion: 03/01/2026","study_completion_date":" 03/01/2026","last_update_posted":"2023-02-17"}]